Tech Company Financing Transactions
Merganser Biotech Funding Round
On 12/31/2012, Merganser Biotech raised $138 thousand in funding from BioAdvance Ventures and private investors.
Transaction Overview
Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$138,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1004 West 9th Ave. 115
King Of Prussia, PA 19406
USA
King Of Prussia, PA 19406
USA
Phone
Website
Email Address
Not Recorded
Overview
Merganser Biotech is committed to the development of new medicines for the treatment of rare hematological and iron overload diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian MacDonald
Chief Operating Officer
Remy Sukhija
VP - Bus. Development
Gene Merutka
Browse more venture capital transactions:
Prev: 12/31/2012: AgInnovation venture capital transaction
Next: 12/31/2012: MFG.com venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC transactions reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs